More News

21 Aug 2017 Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement to Co-Develop Multiple Novel Biologic Therapies
21 Aug 2017 Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies for Respiratory Diseases
18 Aug 2017 Medivir licenses exclusive rights to MIV-802 for Greater China to Ascletis
17 Aug 2017 WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences
17 Aug 2017 Atreca Completes Oversubscribed $35 Million Series B Financing to Advance Novel Cancer Immunotherapies
15 Aug 2017 Takeda Announces Alliance with Stanford University to Drive Therapeutic Discoveries
15 Aug 2017 Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.
15 Aug 2017 HitGen and Aduro Enter Research Collaboration
11 Aug 2017 Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected Checkpoint Fusion Proteins in Immuno-Oncology
11 Aug 2017 Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs
11 Aug 2017 AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline Updates
10 Aug 2017 Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund
10 Aug 2017 Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
10 Aug 2017 Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)
09 Aug 2017 Achillion Reports Second Quarter 2017 Financial Results and Proof-of-Concept With a First-in-Class, Oral Factor D Inhibitor
08 Aug 2017 Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group
08 Aug 2017 Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab
08 Aug 2017 Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 Into Phase I for AML Patients
08 Aug 2017 PreveCeuticalâ„¢ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics
07 Aug 2017 AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
07 Aug 2017 HitGen and LEO Pharma Enter Research Collaboration
07 Aug 2017 Alligator expands immuno-oncology collaboration with Stanford University
05 Aug 2017 Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice
04 Aug 2017 Avelas Biosciences Doses First Patient in Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
04 Aug 2017 Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing